Contents
Recent Patents on Cardiovascular Drug Discovery (Discontinued), Volume 1 - Number 1
Novel Molecular Targets in the Treatment of Cardiac Hypertrophy
, 1(1): 1 - 20Mark Luedde, Hugo A. Katus and Norbert Frey
DOI: 10.2174/157489006775244290
Non-Steroidal LXR Agonists; An Emerging Therapeutic Strategy for the Treatment of Atherosclerosis
, 1(1): 21 - 46David J. Bennett, Andrew J. Cooke and Andrew S. Edwards
DOI: 10.2174/157489006775244245
Methods for Identifying Cardiovascular Agents: A Review
, 1(1): 47 - 56David A. Tulis
DOI: 10.2174/157489006775244236
Recently Patented Applications of Homologous Cellular and Extracellular Agents as Therapeutics or Targets for the Prevention of Restenosis Post- Angioplasty
, 1(1): 57 - 66Rainer Klocke, Lekbira Hasib and Sigrid Nikol
DOI: 10.2174/157489006775244272
Combination of a Sterol Absorption Inhibitor and Cardiovascular Agents for the Treatment of Dyslipidemia
, 1(1): 73 - 78Christina Chrysohoou and Steven Singh
DOI: 10.2174/157489006775244218
Telmisartan, its Potential Therapeutic Implications in Cardiometabolic Disorders
, 1(1): 79 - 83Sho-ichi Yamagishi and Kazuo Nakamura
DOI: 10.2174/157489006775244281
Edaravone (3-Methyl-1-Phenyl-2-Pyrazolin-5-one), A Novel Free Radical Scavenger, for Treatment of Cardiovascular Diseases
, 1(1): 85 - 93Yukihito Higashi, Daisuke Jitsuiki, Kazuaki Chayama and Masao Yoshizumi
DOI: 10.2174/157489006775244191
The Vascular Endothelin System in Hypertension - Recent Patents and Discoveries
, 1(1): 95 - 108Meri M. Hynynen and Raouf A. Khalil
DOI: 10.2174/157489006775244263
New Approaches to Atherosclerotic Cardiovascular Disease. The Potentialities of Torcetrapib
, 1(1): 109 - 114Jose L. Perez-Castrillon and Antonio Duenas- Laita
DOI: 10.2174/157489006775244209
Webmaster Contact: info@benthamscience.org